<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PDGF-A Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PDGFA</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PDGF-A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=PDGFA" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
.infobox .infobox-protein
!!! Info
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PDGF-A Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PDGFA</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PDGF-A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=PDGFA" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
.infobox .infobox-protein
!!! Info
[PDGF-A](/proteins/pdgfa-protein) is a secreted growth-factor subunit in the PDGF family that usually acts as a disulfide-linked PDGF-AA homodimer.[@andrae2008] In brain and spinal cord biology, PDGF-A is best known for maintaining oligodendrocyte precursor cell (OPC) pools, regulating myelination dynamics, and supporting remyelination responses after injury.[@woodruff2004][@hill2014] Because white-matter failure, glial dysfunction, and vascular stress are recurring themes across [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and atypical parkinsonian syndromes, PDGF-A is increasingly treated as a systems-level repair signal rather than only a developmental mitogen.[@bell2010][@bell2020]
PDGF-A is synthesized as a preproprotein that is proteolytically processed and secreted as a cystine-knot growth factor.[@andrae2008] The mature ligand forms PDGF-AA homodimers and can also form PDGF-AB heterodimers with PDGF-B.[@andrae2008] Compared with PDGF-BB, PDGF-AA has stronger functional coupling to PDGFRA-driven programs in glial progenitors and white-matter lineage cells, while showing less pericyte-focused signaling bias.[@woodruff2004][@tallquist2004]
In translational CNS work, this ligand-selectivity matters: investigators using PDGF-AA are often prioritizing oligodendroglial regeneration and synaptic-metabolic support, while PDGF-BB programs often target [blood-brain barrier](/entities/blood-brain-barrier) and pericyte biology through [PDGFR-Beta Protein](/proteins/pdgfrb-protein).[@bell2010][@bell2020]
Classic and modern studies show PDGF signaling is a major regulator of OPC abundance and turnover in both development and adult CNS tissue.[@woodruff2004][@hill2014] In demyelination paradigms, PDGF-driven signaling supports expansion of progenitors that later differentiate into myelinating oligodendrocytes, shaping lesion repair capacity.[@woodruff2004]
White-matter vulnerability is a convergent mechanism across neurodegenerative disorders with gait and executive dysfunction phenotypes. PDGF-A signaling helps preserve the precursor reservoir required for remyelination after inflammatory, ischemic, or toxic stress.[@woodruff2004][@mitew2014] This links PDGF-A to clinically relevant trajectories in disorders where conduction failure and network disconnection amplify cognitive or motor decline.
By sustaining oligodendroglial lineage cells and glial metabolic support programs, PDGF-A may indirectly buffer axonal energy stress and synaptic instability, two processes central to progressive degeneration.[@hill2014][@saab2017]
In AD-spectrum disease, white-matter damage and neurovascular dysfunction are tightly coupled. Although PDGF-B/PDGFRB markers are currently the most mature vascular readouts, PDGF-A remains mechanistically relevant where oligodendroglial failure coexists with vascular injury.[@bell2010][@bell2020][@nation2019] A practical interpretation is that PDGF-A biology may best serve combination strategies that target both myelin lineage repair and barrier stabilization.
PDGF-focused work in PD has emphasized PDGF-BB in early clinical translation, but the broader pathway logic is relevant to PDGF-A as well: trophic support, anti-degenerative signaling, and repair-permissive glial states.[@paul2015][@paul2019] In PD or CBS/PSP settings with white-matter involvement, PDGF-A hypotheses are biologically plausible but remain under-tested in controlled human studies.
Because PDGF-A is deeply linked to OPC kinetics, it is especially relevant in phenotypes where demyelination/remyelination mismatch drives disability progression.[@woodruff2004][@mitew2014] This includes mixed neuroinflammatory-neurodegenerative states where preserving precursor pools may alter long-term network failure.
Exogenous PDGF-AA has conceptual appeal for remyelination programs, but durable benefit likely depends on timing, differentiation context, and co-control of inflammatory barriers that otherwise trap OPCs in a proliferative but non-remyelinating state.[@woodruff2004][@mitew2014]
Instead of direct ligand delivery, pathway-supportive strategies can target downstream survival/metabolic nodes that preserve oligodendroglial competence under chronic stress. This approach may reduce receptor overactivation risks while still leveraging PDGF-A biology.[@hill2014][@saab2017]
For neurodegenerative disease, the strongest design pattern is pairing myelin-lineage support (PDGF-A axis) with neurovascular stabilization (PDGF-B/PDGFRB axis), then layering disease-specific anti-proteinopathy interventions.[@bell2010][@bell2020][@nation2019]
PDGF pathways are pleiotropic and pro-proliferative. Any sustained activation strategy needs dose discipline, target engagement biomarkers, and oncology-aware safety monitoring, especially in older adults with multimorbidity.[@andrae2008][@paul2015] For CNS work, over-proliferation without functional differentiation is a specific risk in remyelination-focused paradigms.[@woodruff2004]